All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 28, 2023
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for May 2, 2023

May 2, 2023
No Comments
Med-tech firms raising money in public or private financings, including: Dariohealth, Dexcom, Opgen.
Read More

Financings for May 2, 2023

May 2, 2023
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Adcentrx, Albatroz, Biomica, Mesoblast, Mezzion.
Read More
Illustration of human papillomavirus (HPV) infection

Antiva targets CIN with topical tablet, raises $53M

May 2, 2023
By Karen Carey
No Comments
A precancerous condition caused by the human papillomavirus (HPV) affects up to 300,000 American women who are diagnosed each year, and yet there are no treatments, just preventive vaccines introduced in 2006 – targeted to younger generations prior to the first sexual encounter. That leaves a large proportion of the female population stuck with a “wait-and-see” approach that involves continuous monitoring of their HPV infection through pap smears to detect cellular changes that could lead to cervical cancer. South San Francisco-based Antiva Biosciences Inc. is seeking to find a better response to this condition known as high-grade cervical intraepithelial neoplasia (CIN2,3) with its lead topical therapeutic, ABI-2280, a prodrug of an acyclic nucleoside phosphonate that is currently in phase I trials.
Read More
World map with connecting lines

Pharmaessentia raises $462M in GDR offering to expand global footprint

May 2, 2023
By Tamra Sami
No Comments
Pharmaessentia Corp. raised $462.7 million in a global depositary receipt (GDR) offering on the Luxembourg Stock Exchange that marks the largest global health care GDR offering so far this year. The capital raise “reflects confidence in the market opportunity for our approved product and the potential of our pipeline,” said Pharmaessentia founder and CEO Ko-Chung Lin.
Read More

Financings for May 2, 2023

May 2, 2023
No Comments
Biopharmas raising money in public or private financings, including: Adma, Anavo, Cyclo, Odimma, Ten63.
Read More
Various pills laid across a target
Drug Design, Drug Delivery & Technologies

Launch of Initial Therapeutics with a focus on selective termination of protein synthesis

May 2, 2023
No Comments
Initial Therapeutics Inc. has launched with a focus on developing medicines that block difficult-to-drug protein targets with a new mode of action – selective termination of protein synthesis (STOPS).
Read More

Financings for May 1, 2023

May 1, 2023
No Comments
Med-tech firms raising money in public or private financings, including: Medshift, Pulse.
Read More
Ciliatech

Ciliatech raises $3.87M in series A funding to develop new-generation implant for glaucoma

May 1, 2023
By Bernard Banga
No Comments
Ciliatech SAS secured $3.87 million in series A funding to continue developing its second-generation implant to treat open-angle glaucoma. This round was led by its historical shareholders, including BNP Development SAS, Kreaxi SAS and individual investor Bernard Chauvin. “With this additional money, we can continue clinical trials to obtain the CE mark,” Olivier Benoit, co-founder and CEO of Ciliatech SAS told BioWorld.
Read More

Financings for May 1, 2023

May 1, 2023
No Comments
Biopharmas raising money in public or private financings, including: Acelyrin, Fibrogen, Jasper.
Read More

Financings for April 28, 2023

April 28, 2023
No Comments
Med-tech firms raising money in public or private financings, including: Genedx.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 391 392 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 26, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 26, 2023.
  • FDA approved icons and medical professional

    Genmab, Abbvie to join Roche with FDA nod for CD20 bispecific in lymphoma

    BioWorld
    Five months after the first anti-CD20xCD3 T-cell engaging bispecific antibody, Roche Holding AG’s Lunsumio (mosunetuzumab), cleared U.S. FDA approval for...
  • Illustration of pancreas

    Gene therapy to reverse T2D shows proof of concept at ASGCT

    BioWorld
    The most ambitious objective of any treatment is to eradicate the disease, acting on its origin to cure it instead of treating its symptoms. This is the purpose...
  • PET imaging of RELN-COLBOS (H3447R) carrier brain showing limited aggregation of tau

    Reelin’ in druggable protective pathways with second Alzheimer’s ‘escapee’

    BioWorld
    Investigators have identified a second individual who remained cognitively normal into his late 60s despite having the PSEN1 E280A mutation, which causes a...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing